Key Insights

Highlights

Success Rate

90% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 37/100

Termination Rate

4.2%

1 terminated out of 24 trials

Success Rate

90.0%

+3.5% vs benchmark

Late-Stage Pipeline

8%

2 trials in Phase 3/4

Results Transparency

44%

4 of 9 completed with results

Key Signals

4 with results90% success

Data Visualizations

Phase Distribution

18Total
Not Applicable (16)
P 4 (2)

Trial Status

Completed9
Unknown8
Withdrawn2
Active Not Recruiting2
Terminated1
Recruiting1

Trial Success Rate

90.0%

Benchmark: 86.5%

Based on 9 completed trials

Clinical Trials (24)

Showing 20 of 20 trials
NCT05504070Not ApplicableActive Not RecruitingPrimary

Venclose digiRF System Post Market Study

NCT03250247Not ApplicableActive Not Recruiting

Chronic Venous Thrombosis: Relief With Adjunctive Catheter-Directed Therapy (The C-TRACT Trial)

NCT06811909Not ApplicableRecruiting

Non-healing Venous Leg Ulcers Treated With Standard Care With or Without BR-AC

NCT03820947Not ApplicableTerminatedPrimary

VenaSeal Spectrum: Global Post-Market Randomized Controlled Trial

NCT06913764Not ApplicableCompleted

First- or Second- Class Compression Hosiery After Endovenous Laser With Sclerotherapy and Ambulatory Phlebectomy

NCT05707169Not ApplicableUnknown

Comparison of Zero- and Two-centimeter Distance From Sapheno-femoral Junction in Laser Ablation of Varicose Vein

NCT05633277Not ApplicableUnknownPrimary

Outcomes of Sclerotherapy of the Ulcer Bed Compared to a Combination of Ablation and Injections

NCT02936271Not ApplicableWithdrawn

Efficacy of Vasculera in Prevention on Post-op Pain and Edema Following Lower Extremity Venous Treatment in the Outpatient Setting

NCT04339088Unknown

High Intensity Focused Ultrasound in PAtients With Varicose Veins in Singapore

NCT04384315Unknown

Efficacy and Safety of Endovenous Radio Frequency (EVRF) for Treatment of Varicose Veins in Singapore

NCT04774939Not ApplicableNot Yet RecruitingPrimary

EVLA and Optimal Timing of Sclerotherapy

NCT04758728Not ApplicableCompleted

Adrenaline Reduces Ecchymoses and Hematomas and Improves Quality of Life After Classic Saphenous Vein Stripping

NCT04339075Unknown

Registry to Investigate the Efficacy and Safety of VenaBlock VeIn SEaling System for VaRicose Veins in SingApore

NCT02553720Not ApplicableCompleted

The ATLANTIS Trial

NCT03893201Completed

A Singapore Venaseal Real World Post-Market Evaluation Study

NCT04146168Unknown

Lake Washington Vascular VenaSeal™ Post-Market Evaluation

NCT04006184Completed

Retrospective Review of Saphenous Vein Incompetence: Venaseal Versus Endovenous Thermal Ablation

NCT02585726Not ApplicableCompletedPrimary

Lake Washington Vascular VenaSeal™ Post-Market Evaluation (WAVES)

NCT00842296Not ApplicableCompletedPrimary

ClosureFAST - Radiofrequency Great Saphenous Vein Treatment

NCT02988063Phase 4Withdrawn

Effect of PEM Treatment of Superficial Axial and Tributary Vein Reflux on Improvement of Wound Healing in VLUs

Scroll to load more

Research Network

Activity Timeline